OOIR: Observatory of International Research

Papers

(The H4-Index of European Heart Journal is 98. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Corrigendum to: Backup natural pacemaker found in the heart	2531
Residual leaks after transcatheter left atrial appendage closure: why and how to assess it?	2430
Intricacies of aortic risk assessment studies: not a simple matter	1853
Pulmonary haemodynamics and pulmonary congestion: where are we now?	1751
The Antwerp score: is this the ‘new hope on the horizon’?	1416
Female representation on editorial boards of the National Societies of Cardiology Journals of the European Society of Cardiology	1261
A rare case of a dorsal mass caused by descending thoracic aortic dissection	986
New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies	965
Corrigendum to: Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled	917
Meet the European Society of Cardiology Gold Medallists 2022	845
Strengthening cardiovascular trials across Australia and New Zealand—the Alliance for Cardiovascular Trials (ANZACT) Network	789
Unmeasured confounding is always unnerving: cannabis and cardiovascular risk	764
Additional value of 18fluorodeoxyglucose positron emission tomography/computed tomography combined with intracardiac echocardiography to detect lead vegetations	749
Obituary Joep Perk	712
Taking inspiration from birds to improve flow in prosthetic heart valves: an European Research Council granted project	707
The extended role of 24 h ambulatory blood pressure monitoring for reflex syncope	585
Risk of knowing too much: the tricky case of estimated glomerular filtration rate and treatment decisions in heart failure	487
Reconsidering safety and reducing barriers to MRI in patients with cardiac implantable electronic devices	464
A case of crowded heart: closing the door after the visitors	423
Isolated early peak cardiac troponin for clinical decision-making after elective cardiac surgery: useless at best	416
Doubly committed ventricular septal defect closure using an eccentric occluder via minimal incision in the anterior median sternum through the left parasternal third intercostal space	361
Elevated serum xylitol levels and cardiovascular risk: an active component or an innocent bystander?	342
Dissecting the effect of genetic variants on atherosclerosis: integrating bulk and single-cell transcriptomics	317
Weekly journal scan: a hard RAFTing to improve long-term survival in heart failure with severely reduced ejection fraction	317
Correction to: The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies	296

Early vascular disease of Olympian Paavo Nurmi despite a healthy lifestyle	254
Bulgarian Society of Cardiology: 50 years on	247
Weekly Journal Scan: no CLEAR evidence of cardiovascular benefits of colchicine after acute myocardial infarction	231
Arterial conduits for coronary bypass grafting: the set-point concept	224
Correction to: Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score	222
Weekly Journal Scan: The promise of small interfering RNA in reducing lipoprotein(a)	210
Do we need new thresholds for surgical repair in patients with ascending thoracic aortic aneurysm disease?	207
One-shot thrombolysis for the management of acute ischaemic stroke	205
Acromegaly and cardiovascular outcomes: a cohort study	200
Colchicine to prevent sympathetic denervation after acute myocardial infarction: the COLD-MI trial	193
Promising perspectives on pregnancy in women with congenital heart disease	185
Can we measurably improve the prediction of recurrent coronary artery disease events?	179
Suspected heart failure: a clinical pattern that calls for action	166
Why Y? The Y chromosome may serve a cardiovascular purpose after all	163
Hypernatremia and subclinical chronic kidney disease	162
Brugada syndrome: can polygenic risk scores help the clinician?	159
The Year in Cardiovascular Medicine 2024: the top 10 papers in interventional cardiology	159
Mischief in the marrow: a root of cardiovascular evil	159
Beyond reproductive health: the cardiovascular risks of endometriosis	156
Moderate mixed aortic valve disease -evaluation, treatment and prognosis of patients referred to heart valve center	154
High resting coronary flow velocity predicts worse survival in chronic coronary syndromes	154
Effect of tafamidis on left atrial function in patients with transthyretin amyloid cardiomyopathy	154
Characteristics and long-term ablation outcomes of supraventricular arrhythmias in hypertrophic cardiomyopathy: a 10-year, single-center experience	151
Screening for subclinical atherosclerosis in patients clinically diagnosed with familial hypercholesterolemia and determination of imaging-guided patient management strategy	151
Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up	147
Abnormal left-sided blood volume, wall shear stress & energy loss in patients with repaired Tetralogy of Fallot identified by 4D flow MRI	147
Effectiveness of empagliflozin in patients with heart failure and COPD: Results from EMPEROR-Preserved and EMPEROR-Reduced	147
Use of emgliflozine in cardiotoxicity treatment. EMPACARD-treatment registry. Six-months follow-up	145
AD-9308 ameliorates the impacts of 4-HNE on the progress of pulmonary arterial hypertension in aldehyde dehydrogenase 212 knock-in mice	145
Elevated markers of liver function are associated with poorer outcomes in HFREF: an analysis of DAPA-HF	142
Vericiguat: a QTc interval study in patients with coronary artery disease	141
Weekly Journal Scan: Angiography-derived fractional flow reserve or intravascular ultrasound to guide stenting of non-complex coronary lesions	140
Evaluating the effect of the antiPCSK9 vaccine on systemic inflammation and oxidative stress in CFA-challenged albino mice	139
Impact of catheter ablation on functional tricuspid regurgitation in patients with atrial fibrillation	130
Allied health professional-physician collaboration to enhance guideline-directed medical therapy of heart failure: expanding therapeutic opportunities	129
Regional distribution of diffuse fibrosis in the basal and mid-ventricular AHA segments in patients with type 2 diabetes	128
Ventriculo-arterial coupling parameters by cardiac magnetic imaging are associated with outcome in patients with a systemic right ventricle	125
Impact of QRS complex fragmentation on all-cause mortality before and after cardiac resynchronization therapy	125
Disparities in the access to atrial fibrillation ablation in Denmark	124
Reporting quality of randomized controlled trials of percutaneous patent foramen ovale closure for the treatment of migraine based on the CONSORT statement	123
Artificial intelligence as a precision tool for predicting risk of in-hospital death after aortic valve replacement	122
The role of process mining tools in STEMI networks: where should we build a new primary PCI centre?	122
High-sensitivity C-reactive protein is associated with cardiac dysfunction and morbidity in a community-based cohort	121
Telomere length across spectrum of metabolic health	121
Functinal assessment in Angina and Non-Obstructive Coronary Arteries (ANOCA) patients: from Microvascular Resistance Reserve (MRR) to different subtypes of Coronary Microvascular Dysfunction (CMD)	121
Feasibility and end-user perceptions of a novel digital care assistant and support program for people after stroke or transient ischemic attack (CAPS)	121
Coronary rotational atherectomy in patients with severe aortic stenosis	121
Efficacy of intravascular lithotripsy (IVL) in coronary stenosis with severe calcification: a systematic review and meta-analysis of 38 studies	120
Temporal trends in infection-related hospitalizations in patients with heart failure: a nationwide study from 1997 to 2017	120
Refining the prognosis of patients with AF using 3D transesophageal echocardiography of the left atrial appendage	118

Association of liver dysfunction with outcomes after percutaneous coronary intervention - a systematic review and meta-analysis	117
Machine learning using cardiovascular magnetic resonance to predict cardiovascular events in patients with acute myocarditis	116
Beyond secondary prevention drugs: added benefit in survival and events of a healthy lifestyle in patients after an acute coronary syndrome	114
Aortic stenosis in homozygous familial hypercholesterolaemia: a paradigm shift over a century	113
Increased right amygdala activity during the hyper-acute phase of takotsubo syndrome	112
Dementia in individuals with severe hypercholesterolemia: Korean nationwide cohort study	112
Location and impact of the infarct-related artery in acute coronary syndrome: insight from the Swiss SPUM- ACS cohort	110
Immortal Time Bias: the hidden confounder in assessing cardiosurgical treatment effects	109
Impact of co-morbidities on survival after heart transplant in females of childbearing age: analysis of the International Society for Heart and Lung Transplantation (ISHLT) Registry	108
Evaluating off-target drug effects seen in RCTs using proteomics and mendelian randomisation	107
Blood biomarkers in left-sided valvular heart disease	107
What is there to EAARN with a CRT implantation? Predictive factors of mortality or clinical deterioration in patients receiving cardiac resynchronization therapy based on pre-implant factors	106
Improving early mortality risk detection in light-chain cardiac amyloidosis patients with routine echocardiographic indicators and mayo staging	106
Extraction of leadless and tranvenous pacemakers: occurrence, causes and complications from a national US database	105
Factors for incorrect automated atrial fibrillation identification in large-scale screening	105
Dietary sodium intake and outcomes: a secondary analysis from SODIUM - HF	104
Does the quality index of adherence to the evidence-based guidelines predict mortality in patients with myocardial infarction?	102
Duration of sinus rhythm after direct current cardioversion does not predict recurrence of atrial fibrillation after subsequent catheter ablation: a multicentre study	101
iRight4Me: individualisation of P2Y12 inihibitors in the realworld practice - an interim report	100
Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure	100
Preserved left ventricular ejection fraction with abnormal myocardial work in sepsis	99
Atrial fibrillation organisation correlates with ventricular response regularity in patients with persistent atrial fibrillation	99
Impact of aortic valve calcium score on conductive disturbances after transcatheter aortic valve implantation: a monocentre retrospective study	98
Optimal CW-Doppler derived parameter for the diagnosis of iatrogenic mitral stenosis during transcatheter edge-to-edge repair for mitral regurgitation	98
Quantitative assessment of myocardial fibrosis by digital image analysis: an adjunctive tool for pathologist ground truth	98